TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35443250

Group type: EXPERIMENTAL
Intervention: Healthy agers (HA)
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Non-HA but not pre-frail
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Pre-frail or frail
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Overall health state transition
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Age effect on health state improvement
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Gender effect on health state trajectory
Number of subjects: 1889
Study: 32909208

Group type: COMPARATOR
Intervention: New LigaSure™ devices
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Reprocessed LigaSure™ devices
Number of subjects: 168
Study: 32980559

Group type: EXPERIMENTAL
Intervention: Auriculotherapy (ear seeds placed on shoulders and muscle relaxation points from 2 hours before surgery until 24 hours after surgery)
Number of subjects: 90
Study: 35532997

Group type: EXPERIMENTAL
Intervention: Promised airtime incentive of 50 BDT (US $0.60) or 5000 UGX (US $1.35)
Number of subjects: 1165

Group type: EXPERIMENTAL
Intervention: Lottery incentive (500 BDT and 100,000 UGX)
Number of subjects: 1165

Group type: COMPARATOR
Intervention: No incentive (control)
Number of subjects: 1165
Study: 32287110

Group type: EXPERIMENTAL
Intervention: Transparent cap-assisted choledochoscopy (Group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic choledochoscopy without transparent cap (Group A)
Number of subjects: 100
Study: 35343882

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 2

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 2
Study: 34271974

Group type: EXPERIMENTAL
Intervention: Nomograms developed from multivariable logistic regressions for predicting 1-year mortality
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Nomograms developed from multivariable logistic regressions for predicting walking ability
Number of subjects: 702
Study: 35397576

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical hysterectomy
Number of subjects: 690

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy
Number of subjects: 690
Study: 34051386

Group type: EXPERIMENTAL
Intervention: AADI extrapolated from AADI/O and AADI/C2 ratios
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: PADI extrapolated from PADI/O and PADI/C2 ratios
Number of subjects: 119
Study: 36300646

Group type: EXPERIMENTAL
Intervention: Inarigivir 25 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inarigivir 50 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inarigivir 100 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inarigivir 200 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inarigivir (all doses)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inarigivir (all doses) during tenofovir treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo during tenofovir treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inarigivir
Number of subjects: 80
Study: 33839277

Group type: EXPERIMENTAL
Intervention: Linked Color Imaging (LCI)
Number of subjects: 700

Group type: COMPARATOR
Intervention: White Light Imaging (WLI)
Number of subjects: 700
Study: 34297735

Group type: EXPERIMENTAL
Intervention: Hugvie (huggable device)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mobile phone only (Control)
Number of subjects: 24
Study: 35901492

Group type: EXPERIMENTAL
Intervention: Olfactory training
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control (safety information)
Number of subjects: 218
Study: 34462990

Group type: EXPERIMENTAL
Intervention: Maternal cash transfers (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 36092972

Group type: EXPERIMENTAL
Intervention: tDCS delivered 3x/week for 8 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham stimulation delivered 3x/week for 8 weeks
Number of subjects: 51
Study: 32304540

Group type: EXPERIMENTAL
Intervention: 20% autologous serum eye drops
Number of subjects: 60

Group type: COMPARATOR
Intervention: Artificial tears (control)
Number of subjects: 60
Study: 36039002

Group type: EXPERIMENTAL
Intervention: Antidepressant use in Black or African descent residents
Number of subjects: 336

Group type: COMPARATOR
Intervention: Antidepressant use in White residents
Number of subjects: 336
Study: 32005073

Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33574660

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 0
Study: 32502795

Group type: EXPERIMENTAL
Intervention: Underwater gait training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Overground gait training
Number of subjects: 21
Study: 33810379

Group type: EXPERIMENTAL
Intervention: Digital smile designed computer-aided 'All on Four' rehabilitation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional 'All on Four' technique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Digital protocol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional protocol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Digital method
Number of subjects: 50
Study: 32657611

Group type: EXPERIMENTAL
Intervention: EC-T (4 cycles of epirubicin 90 mg/m2 + cyclophosphamide 600 mg/m2, followed by 4 cycles of docetaxel 75 mg/m2)
Number of subjects: 280

Group type: COMPARATOR
Intervention: TCb (6 cycles of docetaxel 75 mg/m2 + carboplatin AUC 6)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: EC-T
Number of subjects: 280

Group type: COMPARATOR
Intervention: TCb
Number of subjects: 280
Study: 33239518

Group type: EXPERIMENTAL
Intervention: Physical recovery
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Work-related recovery
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Disability benefits
Number of subjects: 198
Study: 35430924

Group type: EXPERIMENTAL
Intervention: Yarrow liver compresses
Number of subjects: 20

Group type: COMPARATOR
Intervention: No external application (Control)
Number of subjects: 20
Study: 33487470

Group type: EXPERIMENTAL
Intervention: sIPV (inactivated poliomyelitis vaccine made from Sabin strains)
Number of subjects: 1200
Study: 32726529

Group type: EXPERIMENTAL
Intervention: RSV fusion (F) protein nanoparticle vaccine
Number of subjects: 4636

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4636
Study: 35081076

Group type: EXPERIMENTAL
Intervention: Hydrocortisone therapy in immune-adaptive prevalent (IA-P) patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocortisone therapy in immune-innate prevalent (IN-P) patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in IA-P patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in IN-P patients
Number of subjects: 0
Study: 33675704

Group type: EXPERIMENTAL
Intervention: Microfragmented adipose tissue injection using Lipogems technology
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment with hyaluronic acid injection
Number of subjects: 40
Study: 36326712

Group type: EXPERIMENTAL
Intervention: Whole-grain wheat-fiber diet
Number of subjects: 169

Group type: COMPARATOR
Intervention: Low-GI diet
Number of subjects: 169
Study: 34936957

Group type: EXPERIMENTAL
Intervention: Early weaning (EW)
Number of subjects: 16
Study: 34831609

Group type: EXPERIMENTAL
Intervention: Tactical Games Approach (TGA)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Direct Instruction (DI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Service Teacher’s Basketball Unit (STBU)
Number of subjects: 49
Study: 32567439

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 35311438

Group type: EXPERIMENTAL
Intervention: OPTICARE XL CR
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard CR
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 201
Study: 33647171

Group type: EXPERIMENTAL
Intervention: Weekend admission
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Change of treating team
Number of subjects: 753
Study: 32522904

Group type: EXPERIMENTAL
Intervention: 1.5×10^7 cells of a human Muse cell‐based product, CL2020
Number of subjects: 3
Study: 34626059

Group type: EXPERIMENTAL
Intervention: Experimental condition (biceps curls)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control condition (non-exercise)
Number of subjects: 27
Study: 34672445

Group type: EXPERIMENTAL
Intervention: Mean Platelet Volume (MPV) measurement in patients with proven VTE (316 patients)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Mean Platelet Volume (MPV) measurement in control group (124 patients)
Number of subjects: 440
Study: 32241371

Group type: EXPERIMENTAL
Intervention: Yoga‐CaRe program (n = 1,970)
Number of subjects: 3959

Group type: COMPARATOR
Intervention: Enhanced standard care (n = 1,989)
Number of subjects: 3959
Study: 34447851

Group type: EXPERIMENTAL
Intervention: Neostigmine (2.5 mg/100 ml normal saline)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg/100 ml normal saline)
Number of subjects: 200
Study: 35585105

Group type: EXPERIMENTAL
Intervention: 10-Hz tACS
Number of subjects: 0

Group type: COMPARATOR
Intervention: 40-Hz tACS (control frequency)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 33904601

Group type: EXPERIMENTAL
Intervention: Gel containing propolis extract, nanovitamin C and nanovitamin E, used as toothpaste three times/day for 1 month.
Number of subjects: 46
Study: 34654966

Group type: EXPERIMENTAL
Intervention: Preoperative CT-based radiomic nomogram combining clinical and radiomic signatures
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Combined radiomic signature from nodular and perinodular areas
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Radiomic nomogram
Number of subjects: 373
Study: 32661013

Group type: EXPERIMENTAL
Intervention: Molecular point-of-care testing (POCT) for influenza
Number of subjects: 312
Study: 34561695

Group type: EXPERIMENTAL
Intervention: Cobicistat (150 mg q24h orally)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cobicistat with GHB (25 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: GHB alone (25 mg/kg)
Number of subjects: 15
Study: 33672449

Group type: EXPERIMENTAL
Intervention: Multidirectional running sprint training intervention (12 sessions over 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 31
Study: 36351185

Group type: EXPERIMENTAL
Intervention: Yoga practice for 60 minutes per day including Jala Neti thrice a week, Yoga Nidra once a week for 30 days, plus three days for an orientation program.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional treatment (control group).
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Yoga practice (intervention group).
Number of subjects: 24
Study: 33228787

Group type: EXPERIMENTAL
Intervention: On-site testing and antiviral treatment for influenza (baloxavir or oseltamivir depending on age and comorbidities)
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Control arm with routine surveillance for ARI
Number of subjects: 3200
Study: 33186704

Group type: EXPERIMENTAL
Intervention: leronlimab
Number of subjects: 10
Study: 34353069

Group type: EXPERIMENTAL
Intervention: Kinetic energy progressive exercise (PEKE)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Routine intervention (RI)
Number of subjects: 98
Study: 33314786

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing blended with brief Cognitive Behavioural Therapy (MI‐CBT)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC) sessions
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: MI‐CBT
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Both MI‐CBT and EUC
Number of subjects: 234
Study: 35152036

Group type: EXPERIMENTAL
Intervention: TranS‐C and usual care
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual care followed by delayed TranS‐C
Number of subjects: 121
Study: 33797688

Group type: EXPERIMENTAL
Intervention: MA17 (breast cancer)
Number of subjects: 2752

Group type: EXPERIMENTAL
Intervention: PR7 (prostate cancer)
Number of subjects: 2752

Group type: EXPERIMENTAL
Intervention: LY12 (non-Hodgkin’s lymphoma)
Number of subjects: 2752
Study: 32356684

Group type: EXPERIMENTAL
Intervention: Shunt use (31.6% of patients, 25 patients)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Non-shunt use
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Shunt use
Number of subjects: 79
Study: 33684650

Group type: EXPERIMENTAL
Intervention: AA-reduced diet (20% lower levels of lysine, total sulfur AA, and threonine)
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Control diet (highest digestible AA levels)
Number of subjects: 1280
Study: 35086501

Group type: EXPERIMENTAL
Intervention: Patient-centered matching guidelines (PCPM) applied during referral decision-making from inpatient qualified withdrawal program to aftercare.
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: PCPM implementation process evaluated by clinic staff.
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Number of foregoing substance abuse treatments as a predictor for aftercare matching.
Number of subjects: 250
Study: 33719709

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 20 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32302790

Group type: EXPERIMENTAL
Intervention: Focal therapy (FT)
Number of subjects: 2450

Group type: COMPARATOR
Intervention: Radical treatment
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: Focal therapy (FT) with neoadjuvant agents
Number of subjects: 2450

Group type: COMPARATOR
Intervention: Focal therapy (FT) alone
Number of subjects: 2450
Study: 34139896

Group type: EXPERIMENTAL
Intervention: Calorie deprivation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (normal eating)
Number of subjects: 0
Study: 33591230

Group type: EXPERIMENTAL
Intervention: Genetic liability to MDD
Number of subjects: 660937

Group type: EXPERIMENTAL
Intervention: Genetic liability to MS
Number of subjects: 660937

Group type: EXPERIMENTAL
Intervention: Genetic predisposition toward higher BMI
Number of subjects: 660937
Study: 32639376

Group type: EXPERIMENTAL
Intervention: Self-observation method with direct instructions (SO-DI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Self-observation alone (SO)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Direct instruction (DI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 34384043

Group type: EXPERIMENTAL
Intervention: Clay soils
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sandy soils
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Urban soils
Number of subjects: 50
Study: 32445618

Group type: EXPERIMENTAL
Intervention: ROI‐w radiomics model
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: ROI‐r radiomics model
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Combined model (ROI‐w features, albumin, periportal edema)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Comparison of ROI‐w and ROI‐r models
Number of subjects: 137
Study: 33060437

Group type: EXPERIMENTAL
Intervention: PEG+lactulose
Number of subjects: 60

Group type: COMPARATOR
Intervention: SMT (lactulose)
Number of subjects: 60
Study: 34745918

Group type: EXPERIMENTAL
Intervention: Squill oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32878603

Group type: EXPERIMENTAL
Intervention: Probiotic (Weissella cibaria CMU)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 616121608

Group type: EXPERIMENTAL
Intervention: Panretinal photocoagulation (PRP) with intravitreal Ranibizumab (RBZ) injections (study group, SG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP) alone (control group, CG)
Number of subjects: 50
Study: 35739594

Group type: EXPERIMENTAL
Intervention: Virtual Flipped Learning (VFL) using recorded online lectures and post-lecture virtual discussions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Virtual Traditional Learning (VTL) using live video lectures
Number of subjects: 32
Study: 36372680

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (1 ml)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (1 ml)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ringer's lactate (control group)
Number of subjects: 90
Study: 34292510

Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 2604

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2604
Study: 32747213

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study: 35093141

Group type: EXPERIMENTAL
Intervention: NEON Intervention (recorded mental health recovery narratives)
Number of subjects: 0
Study: 32199799

Group type: EXPERIMENTAL
Intervention: Intrauterine balloon for 28 days
Number of subjects: 138

Group type: COMPARATOR
Intervention: Intrauterine balloon for 14 days
Number of subjects: 138

Group type: COMPARATOR
Intervention: Intrauterine balloon for 7 days
Number of subjects: 138
Study: 33346141

Group type: EXPERIMENTAL
Intervention: Early combined immunosuppression (ECI) for 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional management (CM)
Number of subjects: 0
Study: 33974761

Group type: EXPERIMENTAL
Intervention: Leadership knowledge gaps regarding the scope of preceptor challenges, particularly time commitments and the number of preceptors required
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Improving career advancement or promotion criteria to recognize teaching efforts
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enhanced physician well‐being from teaching
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Distributed leadership
Number of subjects: 12
Study: 32615663

Group type: EXPERIMENTAL
Intervention: Saffron pill
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 43
Study: 36066760

Group type: EXPERIMENTAL
Intervention: Urban garden and peer nutritional counseling intervention
Number of subjects: 115
Study: 33955685

Group type: EXPERIMENTAL
Intervention: Response to primary systemic therapy
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Good performance status (ECOG 0–1)
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Response to first‐line therapy
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Initial local irradiation
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Three or more lines of systemic therapy
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Initiative irradiation
Number of subjects: 988
Study: 34254205

Group type: EXPERIMENTAL
Intervention: Early treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed treatment
Number of subjects: 0
Study: 36243386

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) 400 μg inhaled
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 400 μg inhaled
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) 400 μg BID
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 400 μg BID
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 250 μg BID
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 μg BID
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 1000 μg BID
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) 800 μg QD
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fluticasone furoate (FF) 100 μg QD
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fluticasone furoate (FF) 200 μg QD
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fluticasone furoate (FF) 400 μg QD
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) therapeutic range (800 μg/day)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) therapeutic range (1000 μg/day)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) >3-fold above therapeutic dose range (644 μg/day)
Number of subjects: 85
Study: 33528905

Group type: EXPERIMENTAL
Intervention: SBWI+RES (Restorative Hatha yoga)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SBWI+VIN (Vinyasa yoga)
Number of subjects: 50

Group type: COMPARATOR
Intervention: SBWI (Standard Behavioral Weight-loss Intervention)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Yoga session duration
Number of subjects: 50
Study: 33928435

Group type: EXPERIMENTAL
Intervention: AECT in a supine position
Number of subjects: 18

Group type: COMPARATOR
Intervention: Compression-only therapy (CT) in a supine position
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: AECT in a seated position
Number of subjects: 18
Study: 35351696

Group type: EXPERIMENTAL
Intervention: Personalised nutritional plan with cluster-specific meals for 6 days a week and a personalised behavioural change programme via electronic push notifications.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group receiving meals following general dietary recommendations and generic health behaviour prompts.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Personalised nutritional plan
Number of subjects: 100
Study: 33108212

Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI
Number of subjects: 0

Group type: COMPARATOR
Intervention: FF/VI
Number of subjects: 0

Group type: COMPARATOR
Intervention: UMEC/VI
Number of subjects: 0
Study: 32265309

Group type: EXPERIMENTAL
Intervention: Inhaled aztreonam
Number of subjects: 0
Study: 34274784

Group type: EXPERIMENTAL
Intervention: Check-up at a public health clinic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no check-up)
Number of subjects: 0
Study: 32459322

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Intravenous Analgesia (PCIA)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Epidural Analgesia (EDA)
Number of subjects: 248
Study: 35092371

Group type: EXPERIMENTAL
Intervention: Self-Monitoring Quality of Life (SMQOL) intervention
Number of subjects: 225

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 225